MetaVia Share Price

MetaVia Share Price

NASDAQ: MTVA | Micro Cap | Healthcare
$1.13
-$0.14 (-10.67%) Last updated on 19 Nov, 2026 | 00:48 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • FAQs

MetaVia Stock Performance

Open
$1.19
Prev. Close
$1.26
Circuit Range
N/A
Day Range
$1.18 - $1.19
Year Range
$0.57 - $12.68
Volume
868
Average Traded
$1.18

MetaVia Share Price Today

As of 19 November 2026, MetaVia Inc.'s share price is $1.13. The stock opened at $1.19, compared to its previous close of $1.26. During today's trading session, MetaVia Inc.'s share price traded between $1.18 and $1.19, with an average price of $1.18. Over the past 52 weeks, the stock has recorded a high of $12.68 and a low of $0.57. In terms of performance, MetaVia Inc.'s share price has declined by 59.86% over the last six months and is up 42.14% on a year-on-year basis.

MetaVia Share Price Chart

Line chart of the MetaVia price trend over the selected period. The price fell overall, ranging from 1.13 to 1.19, ending at 1.13.
$1.18$1.19
L
Show Current Price
H

MetaVia Stock Fundamentals & Key Indicators

Market Cap
$2.00M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-2.14
Revenue (TTM)
$0.00
Return On Equity (TTM)
-211.76%
Profit Margin
N/A
Debt to Equity
0.42
Quarterly Earnings Growth YoY
-57.40%

MetaVia Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$3.38-$1.93-$3.82-$5.32
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A42.90%-97.93%-39.27%

MetaVia Annual Profit & Loss

All figures in USD

Particulars20242025
Revenue$0.00$0.00
Net Profit-$27.59-$12.97
Net Profit MarginN/AN/A
Income ChangeN/A52.99%

MetaVia Balance Sheet

All figures in USD Million

Particulars20252024
Non Current Assets0.250.19
Current Assets10.8816.07
Total Assets11.1216.26
Non Current Liabilities0.140.06
Current Liabilities5.658.27
Total Liabilities5.798.33
Shareholders' Equity5.337.93

MetaVia Cash Flow

Annually

All figures in USD Million

Particulars20252024
Operating-15.7-24.71
Investing0.0-0.01
Financing9.9618.3

Corporate Actions

Split
Ex-date: 05 Dec 2025

About MetaVia

MetaVia Inc is a clinical-stage biotechnology company focused on developing treatments for liver-related cardiometabolic diseases. Its product pipeline includes DA-1726, an oxyntomodulin analogue that acts as a dual GLP-1 and glucagon receptor agonist, being developed for metabolic and alcohol-associated liver diseases. The company is also developing vanoglipel (DA-1241), a GPR119 agonist, in combination with resmetirom for the treatment of metabolic dysfunction-associated steatohepatitis (MASH).

MetaVia Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$1.20
$1.18
-1.26%
Oct 2026
$1.54
$1.20
-23.89%
Sep 2026
$1.68
$1.57
-7.10%
Aug 2026
$1.51
$1.69
+19.01%
Jul 2026
$1.43
$1.42
-0.35%
Jun 2026
$2.76
$1.43
-49.38%
May 2026
$1.46
$2.81
+93.47%
Apr 2026
$1.23
$1.46
+21.25%
Mar 2026
$1.53
$1.20
-20.53%
Feb 2026
$2.53
$1.51
-37.86%
Jan 2026
$8.55
$2.43
-71.45%
Dec 2025
$0.77
$8.51
+970.44%

MetaVia Share Price FAQs